{
    "organizations": [],
    "uuid": "412f287b7a04629b419caa1c65c34120fc47f083",
    "author": "",
    "url": "https://www.reuters.com/article/brief-corvus-pharmaceuticals-qtrly-net-l/brief-corvus-pharmaceuticals-qtrly-net-loss-per-share-0-58-idUSASB0C8H4",
    "ord_in_thread": 0,
    "title": "BRIEF-Corvus Pharmaceuticals Qtrly Net Loss Per Share $0.58",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 1, 2018 / 9:42 PM / Updated 3 minutes ago BRIEF-Corvus Pharmaceuticals Qtrly Net Loss Per Share $0.58 Reuters Staff March 1 (Reuters) - Corvus Pharmaceuticals Inc: * CORVUS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.58 * Q4 EARNINGS PER SHARE VIEW $-0.77 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:",
    "published": "2018-03-01T23:42:00.000+02:00",
    "crawled": "2018-03-01T23:50:00.036+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "corvus",
        "pharmaceutical",
        "inc",
        "corvus",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "qtrly",
        "net",
        "loss",
        "per",
        "share",
        "basic",
        "diluted",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}